WST(West Pharmaceutical Services, Inc.) · 财务报表

WST(West Pharmaceutical Services, Inc.) 的财务报表:医疗保健,医疗仪器与耗材。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$2.83B$2.89B$2.95B$2.89B$3.07B
毛利润$1.18B$1.14B$1.13B$998.50M$1.10B
营业利润$752.30M$734.00M$676.00M$569.90M$584.90M
净利润$661.80M$585.90M$593.40M$492.70M$493.70M
经营现金流$584.00M$724.00M$776.50M$653.40M$754.80M
自由现金流$330.60M$439.40M$414.50M$276.40M$468.90M
摊薄每股收益$8.67$7.73$7.88$6.69$6.79

West Pharmaceutical Services, Inc. WST